Ahrens Investment Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$51.9K Buy
+2,195
New +$50.4K 0.03% 317
2022
Q3
Sell
-2,220
Closed -$60K 423
2022
Q2
$60K Sell
2,220
-100
-4% -$3.21K 0.03% 304
2022
Q1
$91K Sell
2,320
-300
-11% -$11.6K 0.03% 289
2021
Q4
$120K Buy
+2,620
New +$125K 0.05% 258
2019
Q2
Sell
-6,145
Closed -$206K 169
2019
Q1
$206K Sell
6,145
-37,365
-86% -$1.18M 0.09% 143
2018
Q4
$1.2M Sell
43,510
-68,410
-61% -$2.12M 0.56% 44
2018
Q3
$4.3M Buy
111,920
+88,995
+388% +$3.27M 1.62% 16
2018
Q2
$805K Buy
+22,925
New +$799K 0.34% 64

Other funds holding FFTY

Ahrens Investment Partners's FFTY Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in CapForce IBD 50 ETF (FFTY) in Q1 2023: 2,195 shares worth $51.9K. The stake represents 0.03% of the portfolio and ranks #317 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in FFTY as recently as Q2 2022.

Ahrens Investment Partners first reported a position in FFTY in Q2 2018 and has held it in 8 quarters since. The position peaked at $4.3M in Q3 2018. 47 funds tracked by Wall St. Rank hold FFTY as of Q1 2023.

  • Ahrens Investment Partners held 2,195 shares of CapForce IBD 50 ETF worth $51.9K as of Q1 2023.
  • CapForce IBD 50 ETF was a new Ahrens Investment Partners position in Q1 2023.
  • CapForce IBD 50 ETF made up 0.03% of Ahrens Investment Partners's portfolio in Q1 2023, its #317 holding.
  • Ahrens Investment Partners first reported a position in CapForce IBD 50 ETF in Q2 2018 and has held it in 8 quarters since.
  • Ahrens Investment Partners's CapForce IBD 50 ETF position peaked at $4.3M in Q3 2018.
  • 47 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.